Prevalence of Familial Mediterranean Fever in Children with Cryptogenic Cirrhosis

Fatma İlknur Varol1, Yılmaz Tabel2, Saim Yoloğlu3

  • 1Department of Pediatric Gastroenterology, Hepatology, and Nutrition, Faculty of Medicine, Inonu University, Malatya, Turkey.

Abstract

Insights

Familial Mediterranean fever (FMF) is linked to cryptogenic cirrhosis in children. This study found a high prevalence of FMF mutations in children with unexplained cirrhosis, suggesting FMF as a potential cause.

Area of Science:

  • Pediatric Gastroenterology and Hepatology
  • Autoinflammatory Diseases
  • Genetics

Background:

  • Familial Mediterranean fever (FMF) is an autoinflammatory condition causing recurrent fever and serosal membrane inflammation.
  • Chronic inflammation in FMF can lead to liver damage, including cirrhosis.
  • The etiological link between FMF and cryptogenic cirrhosis in children requires further investigation.

Purpose of the Study:

  • To determine the prevalence of Familial Mediterranean fever (FMF) in children diagnosed with cryptogenic cirrhosis.
  • To evaluate FMF as a potential etiological factor in pediatric cryptogenic cirrhosis.

Main Methods:

  • A prospective cohort study included 44 children with biopsy-proven cryptogenic cirrhosis.
  • Patients underwent MEVF gene analysis to detect FMF-associated mutations.
  • Other causes of chronic liver disease were excluded prior to enrollment.

Main Results:

  • FMF-associated genetic mutations were identified in 9 out of 44 patients (20.45%).
  • Specific mutations found include M694V (2.27%), E148Q homozygous (2.27%), and R202Q (homozygous/heterozygous).
  • Seven patients (15.9%) had other heterozygous mutations.

Conclusions:

  • Familial Mediterranean fever should be considered in the etiological differential diagnosis of cryptogenic cirrhosis in children.
  • The findings highlight a significant association between FMF and unexplained cirrhosis in the pediatric population.

Related Concept Videos

Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
454
Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
739
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
1.5K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
44
Chronic Pancreatitis I: Introduction01:24

Chronic Pancreatitis I: Introduction

The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
346
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
37